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Abstract
Background: Patient recruitment is one of the most difficult aspects of clinical trials, especially for
research involving elderly subjects. In this paper, we describe our experience with patient recruitment for
the behavioral intervention randomized trial, "The relaxation response intervention for chronic heart
failure (RRCHF)." Particularly, we identify factors that, according to patient reports, motivated study
participation.
Methods: The RRCHF was a three-armed, randomized controlled trial designed to evaluate the efficacy
and cost of a 15-week relaxation response intervention on veterans with chronic heart failure. Patients
from the Veterans Affairs (VA) Boston Healthcare System in the United States were recruited in the clinic
and by telephone. Patients' reasons for rejecting the study participation were recorded during the
screening. A qualitative sub-study in the trial consisted of telephone interviews of participating patients
about their experiences in the study. The qualitative study included the first 57 patients who completed
the intervention and/or the first follow-up outcome measures. Factors that distinguished patients who
consented from those who refused study participation were identified using a t-test or a chi-square test.
The reason for study participation was abstracted from the qualitative interview.
Results: We successfully consented 134 patients, slightly more than our target number, in 27 months.
Ninety-five of the consented patients enrolled in the study. The enrollment rate among the patients
approached was 18% through clinic and 6% through telephone recruitment. The most commonly cited
reason for declining study participation given by patients recruited in the clinic was 'Lives Too Far Away';
for patients recruited by telephone it was 'Not Interested in the Study'. One factor that significantly
distinguished patients who consented from patients who declined was the distance between their
residence and the study site (t-test: p < .001). The most frequently reported reason for study participation
was some benefit to the patient him/herself. Other reasons included helping others, being grateful to the
VA, positive comments by trusted professionals, certain characteristics of the recruiter, and monetary
compensation.
Conclusions: The enrollment rate was low primarily because of travel considerations, but we were able
to identify and highlight valuable information for planning recruitment for future similar studies.
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Background
Patient recruitment in clinical trials is recognized as one of
the most difficult aspects of the study process [1,2].
Recruitment among elderly patients who have chronic
diseases poses particular challenges [3-7]. Studies have
identified that transportation is a specific issue in recruit-
ment of the elderly [1,8]. A trial that requires frequent
travel for a behavioral intervention at a study site, which
can be a long distance away from the patient's residence,
adds difficulties to recruitment among the elderly [7].
These two complicating factors increased the recruitment
challenges in the clinical trial, "The relaxation response
intervention for chronic heart failure (RRCHF)."
The RRCHF was a three-armed, randomized controlled
trial designed to evaluate the efficacy and cost of a 15-
week relaxation response intervention conducted on vet-
erans with chronic heart failure (CHF). The relaxation
response is a state in which individuals evoke a bodily
calm that has the opposite effect of the fight-or-flight
response, with concomitant favorable physiological
changes. Studies have shown that the relaxation response
is effective in managing various medical conditions
including hypertension, insomnia, anxiety, and depres-
sion [9-14].
The primary aim of the RRCHF was to evaluate the efficacy
of the relaxation response in the improvement of the car-
diac function and quality of life of CHF patients. Two con-
trol groups were used: a 15-week cardiac education group
and a usual care group. The original plan was to recruit a
total of 120 patients in 14 months to be randomized into
the three study groups with equal numbers in each group.
A number of factors contributed to the challenge in
patient recruitment for this study: 1. strict inclusion crite-
ria in cardiac function status limiting the number of
potentially eligible patients; 2. high comorbidity among
Veterans Affairs (VA) patients increasing the burden to
patients of time spent receiving care or participating in a
study; 3. the age of VA patients with CHF making travel to
the hospital for the intervention an issue due to either the
lack of the means of transportation or an inability to
drive; 4. the large catchment areas of the VA acute care
hospital at which we were conducting the study, poten-
tially requiring study subjects to travel long distances to
the study site; 5. study protocol requiring 15 weeks of
group attendance in the hospital, which can be a burden
for the elderly with numerous comorbidities; and 6. one
of the study outcomes requiring a bike test, which is not
possible for some patients due to disability or certain
heart conditions.
Despite the challenges we faced in patient recruitment for
this behavioral intervention trial, we successfully recruited
the target number of patients. In this article we describe
the experience in patient recruitment for this trial, includ-
ing the steps we took to modify the recruitment strategies.
We document reasons patients gave for refusing to partic-
ipate in the study, and we discuss factors that are associ-
ated with agreeing to participate. We also identify factors
that motivated participation in the study based on a qual-
itative sub-study. What we learned in this study is helpful
for planning future studies with similar features.
Methods
Study design
The study design consisted of a randomized clinical trial
that included three study groups: relaxation response, car-
diac education, and usual care. The cardiac education
group was used as a comparison intervention to the study
intervention, relaxation response. The education group
also served as a control group in order to eliminate possi-
ble effects associated with group meetings and for
patients' expectations for improvement simply by partici-
pating in the intervention (Hawthorne Effect). This study
was approved by the institutional review boards at the VA
Boston Healthcare System and the VA New England
Health Care Bedford division.
Study population inclusion and exclusion criteria
The targeted patient population in this study consisted of
ambulatory CHF patients of either gender and any race
who visited the VA Boston Health Care System at the cam-
puses of either Jamaica Plain or West Roxbury during the
study period and who met the following inclusion crite-
ria: 1) moderate levels of symptom severity (a New York
Heart Association classification of II or III); 2) left ven-
tricular ejection fraction (LVEF) ≤ 40%; and 3) undergo-
ing pharmacological treatments according to established
clinical guidelines (i.e., ACE inhibitors and the more
recently recommended drug treatment, β-blockers). How-
ever in the early stage of patient recruitment, we noticed
that a substantial number of patients were not under the
treatment of ACE inhibitors or β-blockers, we therefore
dropped the inclusion criteria on medication treatment.
The exclusion criteria were: 1) participation in a rehabili-
tation program that included exercise training and an edu-
cation group; and 2) cognitive impairment as measured
by the Mini Mental Status Examination (MMSE), a relia-
ble and valid screening instrument for the detection of
cognitive impairment. A commonly used cut-off point of
24 (<24) on the MMSE was used to identify patients as
cognitively impaired.
Clinical sites
The CHF clinic in the VA Boston Healthcare System was
the primary recruitment site. The chief of the clinic at the
time during the study period was one of the co-investiga-
tors of the study. She facilitated study recruitment by help-
ing to identify potentially eligible patients in her clinicBMC Medical Research Methodology 2004, 4 http://www.biomedcentral.com/1471-2288/4/8
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and informing patients about the study. After a few
months of recruitment, it became apparent that the
recruitment rate was lower than expected and that the
CHF clinic did not provide enough potentially eligible
patients for the study. We therefore extended the recruit-
ment sites, first to all the cardiology clinics and then to the
primary care clinics to capture CHF patients who visited
those clinics.
Recruitment methods
Clinic recruitment
We first identified patients with a CHF diagnosis (ICD-9
codes of 428, 428.0, 428.1, and 428.9) based on the diag-
noses listed in the VA medical centers' outpatient database
that contains all diagnostic and procedural information
routinely collected in the VA hospitals. We then obtained
the information on the LVEF from the computer files in
the VA to screen patients for the eligibility criteria of LVEF
≤ 40%. The LVEF information was available only for those
patients who took at least one of three tests: catheteriza-
tion, echocardiogram and radionuclide ventriculogram.
Referencing lists of potential study participants, the
recruiters approached the patients when they came to the
clinics for their regularly scheduled appointments. The
physicians and nurses in the clinics, informed about the
study, also assisted in referring patients for recruitment.
Due to the budget constraints and the limited availability
of the recruiters, not all the clinic days were covered for
patient recruitment. Since there was no systematic pattern
of choosing the days for recruitment, no selection bias was
expected.
Telephone recruitment
Approximately one year after the clinic recruitment
started, we added telephone recruitment to the protocol
in an effort to increase the recruitment rate. The patients
who were targeted for telephone recruitment were those
with a CHF diagnosis and LVEF ≤ 40% who had visited the
hospitals in the VA Boston Health Care System at least
once in the past year and had not been screened in the
clinic for the study. We sent letters to the targeted patients
to inform them of the study and then followed-up with
phone calls to recruit them into the study. Patients were
given the option to return postcards if they did not want
to receive the phone calls. Those patients who expressed
interest in study participation over the phone were sched-
uled to come in to the clinic for further screening based on
cognitive impairment. The Mini Mental Status Examina-
tion, requiring an in-person interview, was used to deter-
mine eligibility.
Flyers
Recruitment flyers were posted in the Jamaica Plain and
West Roxbury campuses of the VA Boston Health Care
System. We selected those two locations exclusively
because we had access to the required LVEF data only for
patients who visited those two hospitals. Patients who vis-
ited those two facilities were also more likely to partici-
pate in the study because they were the specified sites for
the study.
Recruitment monitoring
The recruitment statistics were generated monthly and
presented to the co-investigators of the study and to the
recruiters. The statistics included the total number of
appointments of CHF patients in the clinics, the number
of patients to be screened (those with LVEF ≤ 40%), the
number of "no show" patients, the number of patients
screened, and the number of patients who consented and
enrolled. Patients were defined as having consented to
participate in the study when they signed the consent
forms. "Enrolled" patients were those who consented and
completed the baseline assessments. Enrolled patients
were randomly assigned to one of the 3 study groups:
relaxation response, cardiac education, and usual care
groups.
Study intervention
Enrolled patients who were randomized into the relaxa-
tion response group were required to attend a 90-minute
group session each week for 15 weeks to learn various
techniques to elicit the relaxation response. The tech-
niques are breathing awareness, mental repetition of a
word, sound, phrase, or prayer, mindfulness meditation,
guided body scan, progressive muscle relaxation, and
guided imagery. Three tapes with instructions on each of
these techniques were used in the group sessions. Patients
were also asked to practice the techniques at home for 15
to 20 minutes twice a day using these tapes.
Cardiac education program
Enrolled patients who were randomized into the cardiac
education group were required to attend a 90-minute car-
diac education lecture each week for 15 weeks. This edu-
cation group was organized by the cardiac rehabilitation
education program at the VA Boston Health Care System.
The speakers of this ongoing education program are
experts in each of the topic areas. The topics included
medical, pharmaceutical, life style, nutrition, and psycho-
social issues affecting people with heart disease and
related conditions.
Usual care
Patients who were randomly assigned to the usual care
group were not required to attend any group session.
However, similar to patients in the relaxation response
and education groups, they were expected to complete the
questionnaires and undergo the exercise test at baseline,
15 week, 6 month and 12 month follow-up.BMC Medical Research Methodology 2004, 4 http://www.biomedcentral.com/1471-2288/4/8
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Patient compensation
To compensate the time and efforts patients spend for the
study, patients were reimbursed with $50 for completing
the first half of the study (baseline and first follow-up
assessments) and again another $50 after the completion
of the whole 12-month study. Participants were also reim-
bursed for the mileages traveled to the study sites for
attending group sessions or bicycle exercise tests.
Data collection and data analysis
Patient demographic characteristics, address (used to cal-
culate the distance between the patients' residence and the
study clinical site), LVEF, and cardiac medication prescrip-
tions were collected during screening and from the VA
administrative database. A t-test and a chi-square test were
used to compare between patients consented and refused
as well as between patients enrolled and withdrawn after
consenting.
A qualitative study was added approximately one year
after the recruitment started. The first fifty-seven patients
who finished the study intervention and/or the first fol-
low-up outcome assessment were included in the qualita-
tive study. Among these 57 patients, 21 were in the
relaxation response group, 21 were in the education group
and 15 were in the usual care group. These patients were
interviewed by telephone about their experiences in the
study. An open-ended question was included in the inter-
view about the reasons for their participating in the study.
All interviews were audio-taped, transcribed, and the data
were analyzed. A content analysis was conducted by two
study staff who independently coded and categorized the
reasons for study participation. The two coders reached
almost perfect agreement. The few instances of disagree-
ment in coding were resolved in group discussions by the
team.
Results
Enrollment rates
Clinic recruitment
The clinic recruitment period lasted for two years and
three months, starting in April 2000 and ending in June
2002. This recruitment period was extended from the
original planned 14 months due to the lower than
expected recruitment rate.
A total of 1,920 CHF patients had appointments on the
recruitment days in the targeted study clinics (Figure 1).
Among these patients, approximately 29% were eligible. A
high LVEF and the unavailability of LVEF were the two
main reasons for ineligibility (67% and 27%, respec-
tively). These patients were classified as ineligible before
screening. The total number of patients who remained eli-
gible for clinic screening was 551. Of these patients, a total
of 482 were screened; sixty-nine did not show up on any
of the recruitment days. Among the screened patients, 315
(65%) declined, and 124 (26%) consented to participate
in the study. A small percentage (N = 36, 7%) of patients
were screened as ineligible for the following three main
reasons: 1. New York Heart Association Classification of I
or IV indicating mild and severe disease symptomatology
(37%); 2. currently practicing relaxation response (18%);
and 3. currently enrolled in a cardiac rehabilitation pro-
gram (16%). Seven patients did not complete the screen-
ing and could not be reached afterward.
Of the 124 patients who signed the informed consent
form at the time of recruitment, 31% (N = 39) did not
come back for the baseline assessment. These patients
were considered as withdrawing before enrollment. In fol-
low-up calls, patients gave three main reasons for not con-
tinuing with the study: 1. health concerns/too sick; 2. too
busy/schedule conflicts with the group meeting times;
and 3. lost interest in the study. We calculated the enroll-
ment rate as the number of patients who completed the
baseline assessment (so called "enrolled patients") over
the total number of patients screened in the clinic. The
enrollment rate in the clinic was 18% (85/482).
Telephone recruitment
Most of the telephone recruitment was conducted during
a three-month period from February through April, 2001.
During this time period, letters were sent to 351 target
patients inviting them to participate in the study. (See
Methods section for the targeted patient criteria.) Seventy
patients returned the postcard indicating they did not
wish to be called. Telephone recruiters for the study were
able to reach 110 patients by phone to invite them to join
the study. Among them, only seven agreed to participate
and were enrolled in the study. The enrolled rate was 6%,
calculated as seven enrolled among 110 contacted by
phone. Due to this low yield rate, the rest of the 178 target
patients were mailed letters asking them to mail back the
enclosed postcard if they were interested in receiving a
phone call to learn about the study. Among them, only
thirteen (7%) showed an interest by returning the post-
card, and only three of those thirteen enrolled in the
study. The enrollment rate was 2% when calculated as
three patients enrolled among 178 patients who were
mailed a letter.
Flyer
Only a small number of patients responded to the flyer.
None of these patients was eligible due either to a high
LVEF or not having a CHF diagnosis.BMC Medical Research Methodology 2004, 4 http://www.biomedcentral.com/1471-2288/4/8
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Flow Diagram of Patient Recruitment Figure 1
Flow Diagram of Patient Recruitment
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Reasons for refusing to participate in the study
We documented the reasons patients gave during recruit-
ment for refusing to participate in the study. These reasons
were given by patients unprompted. The reasons given by
patients screened in the clinics were grouped into six gen-
eral categories: 1. lives too far away (26%); 2. time con-
straints (22%), including too busy, too many
appointments, and works on the day the study group
meets; 3. not interested in the study (19%); 4. health
problems (12%); 5. transportation problems (11%); and
6. others (10%). For patients screened by telephone, there
were four main reasons: 1. not interested in the study
(39%); 2. lives too far away (26%); 3. health problems
(21%) and 4. too busy (7%).
Factors related to consent to the study
We compared patients who consented to participate in the
study (N = 134) with those who refused to participate (N
= 407) (Table 1). Patients who consented were younger
(mean age of 70 vs. 73 years old) and were more likely to
be non-white (mainly African American). The compari-
son by race was inconclusive however because of the high
percentage of unknown race among patients who refused
enrollment. The majority (99%) of both groups were
male. Patients who consented and patients who refused
had similar LVEF, indicating similar systolic function.
Medication treatments for CHF were also comparable for
the two groups of patients; a similar percentage (p value >
.05) in each group received the two standard medications:
β-blockers, and ACE inhibitors. A key factor in consenting
to participate in the study was the distance between the
patient's residence and the VA medical center where the
study was conducted. Patients who consented lived an
average of nine miles closer to the study site than patients
who refused.
Factors related to withdrawal after consenting to the study
Of the 134 patients who consented to the study either
through the clinic or telephone recruitment, 95 finished
the baseline assessments on the outcome measures. We
compared these 95 patients with the 39 patients who
withdrew from the study after signing the informed con-
sent form. These two groups of patients were not statisti-
cally different in age, race, LVEF, or the distance from their
residence to the VA hospital. Between the two groups of
patients, similar (i.e., no statistical difference) percentages
of patients received the β-blockers and ACE inhibitors.
Reasons for participating in the study – results from the 
qualitative study
Six general categories emerged in coding patients'
responses to the question about the reasons for their study
participation: 1. benefit to self; 2. benefit to others,
including the VA; 3. gratitude to the VA; 4. positive com-
ments by a trusted professional; 5. certain characteristics
of the recruiter; and 6. monetary compensation.
Benefit to self
For the majority of patients (34 out of 57), the primary
motivation for participation in the study appeared to be
the desire to gain some benefit to themselves. These pro-
jected benefits ranged from learning more about the ori-
gin and manifestations of their condition, to learning
additional ways to cope with their symptoms and limita-
Table 1: Characteristics of Patients Consented or Refused to Study Participation
Consented Patients N = 134 Refused Patients N = 407 P-value*
Patient Characteristics
Age (year)
Mean (SD) 69.9 (9.6) 73.0 (9.7) 0.002
Race
White 83% 84% 0.001
No-white (mainly African American) 15% 7%
Unknown 2% 9%
Cardiac Systolic Function
LVEF (%)
Mean (SD) 31.3 (7.0) 31.7 (7.9) 0.56
CHF Medication
ACE-Inhibitors 82% 75% 0.08
β-Blockers 76% 71% 0.27
Distance between Residence and 
Study Site (Mile)
Mean (SD) 21.7 (21.4) 31.3 (33.6) 0.0002
*: P-value of statistical tests of t-test or chi-square test, comparing patients consented vs. refused to study participation.BMC Medical Research Methodology 2004, 4 http://www.biomedcentral.com/1471-2288/4/8
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tions, to easing the boredom and inactivity brought about
by their imposed lifestyles.
Many patients reported that it "couldn't hurt" or "might
help" to gain more knowledge.
Well, I was looking for something.... I wanted to find out more
about the heart, and I intended to learn more about it. Not only
the heart, but every thing else, the dietician and so forth.
Some patients specifically joined to explore new ways, or
learn new techniques to cope with their conditions.
Well, I felt as though when I said no about the whole thing,
after I thought about it, I said, I might get some benefit out of
it.... Because then I got to thinking, I said You know, to sit in
on a meditating class is big bucks if I had to spin it out of my
pocket. So I'm saying I'm getting this for nothing and getting a
little incentive on top of that. So I says, Well, I have to go and
see.
Some patients just thought that participation in the study
would ease the burden of a restrictive and often inactive
lifestyle imposed by their condition.
I guess just to get involved with something... just to have some-
place to go and something to do.
Benefit to others
A large number of patients said that they participated in
the study to help others, either other people with the same
condition or health research in general.
If you can't do anything to help your fellow man, and you have
the opportunity, and it's not painful, it's not costing you any-
thing but a little time and you don't do that, I think there's
something wrong with you.
Gratitude to the VA
Several patients emphasized that they agreed to partici-
pate because of their deep gratitude to the VA for the care
given; they were happy to help the VA in its research and
clinical efforts.
I figured anything that could help patients or the VA, I'm for it
and I will do it again.
One man credited the VA with saving his life.
I am extremely grateful to the VA... for saving my life because
a civilian hospital wouldn't do anything for me. And I feel that
anything I can do to contribute to studies of this nature, I'm
more than happy to do.
Another spoke of his positive relationship with the VA
when asked why he joined the study.
And probably more my relationship with the VA. I get criticized
at times, 'why are you a guinea pig for everything?' I said, I just
feel that they've done so much good for me that if I can get
involved in some program that maybe some new information
will be developed or additional information that I'm more than
willing and happy to do that.
Positive comments by trusted professional
Positive comments from their doctor or trusted clinician
regarding the study appeared to be a very strong motivator
in patient recruitment.
I thought it was just a good idea. I said, 'What the hell, they
wouldn't have asked me to join the class if it wasn't going to
help me... So I said, sure, why not? And uh, Dr. xxxx suggested
it was a good idea and my lead nurse Mrs. XXXX said it's a
good idea to follow these programs. So I said, what the hell, if
they think it's good enough for them, why not?
Recruiter
The appearance, personality, manner, and gender of the
recruiter emerged as an extremely important factor in the
recruiting process. A number of patients in this study even
stated that they joined specifically because they were
impressed by the recruiter. A light-hearted flirtatious
strain also appeared to enhance a positive response.
Because a young lady lassoed me down in the waiting room at
West Roxbury and was very persuasive.
One man openly stated his attraction for the female
recruiter.
The first interviewer that interviewed me was female... and very
attractive, and I said, by golly, this can't hurt... I'd rather look
at her or someone like her you know than a blank page, you
know?... And then I wasn't disappointed because... I really had
hopes that it might do something and it was pleasant.
Another expressed enjoyment at the meeting with the
recruiter.
Well, I remember that day I talked to [the recruiter] in West
Roxbury... Nice little girl, yes... It just was a pleasant meeting,
and I enjoyed meeting her, and it seemed like a good sense
thing to do.
One patient stressed that he was most impressed with the
recruiter's competence and intelligence.
I think that when I was recruited, they talked about how it was
good for the heart, and it relaxes. It just sounded like it wouldBMC Medical Research Methodology 2004, 4 http://www.biomedcentral.com/1471-2288/4/8
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be good for me... It would help me; it relaxes me and could help
my heart... I think the girl was a good recruiter. I was a field
manager all my life. I owned my own company and trained my
own sales people. And she was good.
One patient was so impressed by the recruiter and the
belief that she would be a part of the study that even
though he could not immediately participate, he agreed to
join at a future date. When he began the program and real-
ized that the recruiter was not part of it, he expressed dis-
appointment, but enjoyed the study nevertheless.
I was over at West Roxbury, and [the recruiter] came up to me
and... I said I really can't do it, I don't have the time.... So I
said if you wait till November, I'll do it.... So she's the one that
talked me into it.... And then I find out she's gone!.... She spent
about a half hour with me in there.... She says I really would
love to have you in the class.... She said we really would love to
have you come. I said I can't go until November when I have a
few less appointments.... I started last November.
Monetary compensation
While some patients said that the monetary compensa-
tion was a nice feature and they were happy to get it, they
stressed that they would have joined the study even with-
out the money. Only one patient said he joined the study
just for the money.
Discussion
Although a number of barriers made recruitment a chal-
lenge, this behavioral intervention trial was successful in
obtaining a recruitment number beyond its original goal
of 120 consenting patients. We attribute this success to the
following two factors: close monitoring of the recruitment
and a flexible protocol. By closely monitoring recruit-
ment, we recognized in the early stages that the recruit-
ment rate was lower than expected. We were then able to
act in a timely manner to change our recruitment strate-
gies and study protocol. The changes in recruitment strat-
egies included: 1) extending recruitment clinics to include
cardiology and primary care clinics in addition to the orig-
inally designated heart failure clinic; 2) extending the
recruitment period from the originally planned one year
and two months to two years and three months; 3) adding
telephone recruitment. Although the yield rate was low,
the ten patients recruited and enrolled from the telephone
recruitment were, nevertheless, a valuable addition to the
study. The changes in the study protocol consisted of the
following: 1) allowing patients who could not do the exer-
cise test using a bicycle (one of the two study outcomes)
to enroll in the study; and 2) allowing patients who were
not on the two major medications for treating CHF to
enroll in the study. Twenty-two percent of the enrolled
patients could not do the bike test. This change, therefore,
proved very valuable. For those patients who could not do
the bike test, the other study outcome, quality of life
measures, was available for analysis. Around 20% of con-
senting patients were not receiving each of the two medi-
cations. We will control for medication use in the analysis
when we evaluate the intervention effect to account for
the possible confounding effect of medication on the
study outcome.
Although the target number of patients agreed to partici-
pate, only 71% (N = 95) of those patients actually com-
pleted the baseline outcome assessments and enrolled in
the study. Since it was necessary to schedule the bicycle
exercise test some time after the recruitment, patients had
time to change their minds about participation. This fac-
tor needed to be taken into account when we estimated
the enrollment rate in the study planning stage. We had a
higher enrollment rate using face-to-face recruitment in
the clinic than using telephone recruitment. However, we
were able to enroll only one patient per 5–6 patients
approached in the clinic. With telephone recruitment, we
only enrolled 6 patients per 100 patients contacted. The
flyer was totally unsuccessful for recruitment because all
the patients who called as a result of seeing it were not eli-
gible due to a high LVEF or a lack of the CHF diagnosis.
Our experiences indicate that for a behavioral interven-
tion trial that requires patients to travel frequently to the
intervention site and also requires laboratory data, face-
to-face recruitment is the best choice. Even using a face-to-
face recruitment approach, however, one should expect to
have an enrollment rate that is much lower than the rate
for studies that only require patients to fill out
questionnaires.
Our recruitment experience also provided information on
why patients declined to participate in the study. The top
reasons given by patients who declined to participate in
the study included living too far away, travel difficulties,
and time constraints. These reasons were justified given
the elderly study population with multiple comorbidities
and the study requirement of frequent travel to the inter-
vention site. These findings are consistent with other stud-
ies that also found that transportation, travel difficulties,
and time commitment, are among the most common bar-
riers for study participation, particularly for the elderly
[1,15]. Our analysis comparing the patient characteristics
between those who consented and refused to participate
in the study confirmed that the distance between a
patient's residence and the study site was a strong deter-
mining factor for study participation.
One important protocol change in this study was the
addition of a qualitative piece consisting of telephone
interviews with patients about their experiences in the
study. As indicated in the literature, qualitative studies can
provide valuable information about how and why inter-BMC Medical Research Methodology 2004, 4 http://www.biomedcentral.com/1471-2288/4/8
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vention works [16,17]. This type of information is espe-
cially important for an intervention such as the relaxation
response. The benefits that patients could obtain from the
intervention might not be captured by the standard qual-
ity of life measures.
During the qualitative interview, for the purpose of help-
ing with recruitment, we also asked patients why they
decided to enroll in the study. The reason given by most
of the study participants was for some benefit to self.
Although patients were informed that no beneficial effect
was to be expected, their decisions to participate in the
study carried the expectation that they would benefit from
it in some way. Patients defined benefits differently, rang-
ing from learning more about their medical condition to
helping them cope with imposed lifestyle changes. Other
reported reasons for study participation included helping
others, money, gratitude to the VA, or because of positive
comments from a doctor, nurse, or clinician. The latter
two motivations suggest the value of conducting a study
within the VA health care system and the importance of
informing relevant healthcare providers about planned
clinical studies. Another important factor contributing to
successful recruitment is the recruiter. Our experience
with this study indicates that the personality, gender, con-
fidence, competence, and attractiveness of the recruiter are
extremely important factors in successful recruitment.
In general, the most effective recruitment involved a
direct, personal approach. Patients appeared to enjoy
being noticed and singled out for something presented to
them as important and special ("I was asked to do it.");
they responded to the implication that their participation
was needed and appreciated ("I really would love to have
you in the class.... We really would love to have you
come."). Only one patient specified that he responded to
a written notice. Implicit in this phenomenon is the
patient's positive response to feeling needed or cared
about; he feels special because he is singled out for his
potential to help, whether it's himself, others, the VA in
particular or humanity in general. Only one patient
reported that money was his only motivation.
Based on our experiences in this study, we have learned a
number of valuable lessons for successful patient recruit-
ment: 1) Close monitoring of recruitment statistics is
important; 2) Flexibility in protocol change is essential; 3)
A successful recruiter requires certain specific characteris-
tics; 4) Patient recruitment can be very time consuming
and costly; and 5) Sufficient budget for recruitment per-
sonnel is necessary. Some of these lessons have been high-
lighted in other studies. For example one trial was
successful in increasing recruitment rate through adopting
flexible recruitment strategies based on the finding from a
qualitative study within the trial [18]. With the experience
we gained from this study, we recommend the following
considerations for studies with similar features to this
one: 1) Carefully evaluate the available transportation
options in study planning; 2) Consider a multiple-site
study; and 3) Adopt alternative intervention methods that
allow patients to have the intervention at home, such as
home study video tapes or Internet-based two-way video
conferencing.
Conclusions
Although patient recruitment for clinical trials is a chal-
lenge, our experiences from the relaxation response inter-
vention for chronic heart failure trial revealed factors that
can contribute to recruitment success. Close monitoring
of recruitment and flexibility in protocol change are the
Table 2: Characteristics of Patients Enrolled or Withdrawn after Consenting
Enrolled Patients N = 95 Withdrawn Patients N = 39 P-value*
Patient Characteristics
Age (year)
Mean (SD) 70.0 (9.7) 69.8 (9.4) 0.89
Race
White 86% 82% 0.65
No-white (mainly African American) 14% 18%
Cardiac Systolic Function
LVEF (%)
Mean (SD) 31.2 (7.1) 31.5 (6.7) 0.78
CHF Medication
ACE-Inhibitors 82% 81% 0.85
β-Blockers 78% 70% 0.33
Distance between Residence and Study Site (Mile)
Mean (SD) 23.3 (23.6) 17.5 (13.7) 0.09
*: P-value of statistical tests of t-test or chi-square test, comparing patients enrolled vs. withdrawn after consenting.Publish with BioMed Central    and   every 
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two keys for successful recruitment. Personal characteris-
tics of the recruiters is also an important factor. Finally,
careful planning including allocating a sufficient budget
for recruitment is essential for success.
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